Advertisement
UK markets close in 3 hours 12 minutes
  • FTSE 100

    8,097.94
    +57.56 (+0.72%)
     
  • FTSE 250

    19,732.27
    +12.90 (+0.07%)
     
  • AIM

    755.45
    +0.76 (+0.10%)
     
  • GBP/EUR

    1.1669
    +0.0024 (+0.21%)
     
  • GBP/USD

    1.2506
    +0.0043 (+0.35%)
     
  • Bitcoin GBP

    51,207.48
    -2,039.09 (-3.83%)
     
  • CMC Crypto 200

    1,356.80
    -25.77 (-1.86%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.13
    +0.32 (+0.39%)
     
  • GOLD FUTURES

    2,341.40
    +3.00 (+0.13%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,994.76
    -93.94 (-0.52%)
     
  • CAC 40

    8,022.82
    -69.04 (-0.85%)
     

Drugmakers Cancel Price Hikes After California Law Takes Effect

Drugmakers Cancel Price Hikes After California Law Takes Effect

A handful of the world’s biggest drugmakers are canceling or reducing planned price increases in the U.S., following a new California drug pricing transparency law and continued political pressure over pharmaceutical costs. The California law, which began to take effect earlier this year, requires drugmakers to give insurers, governments and drug purchasers advance notice of large price increases, as a way of publicly pressuring pharmaceutical companies to keep prices down. In the past three weeks, Novartis AG, Gilead Sciences Inc., Roche Holding AG and Novo Nordisk A/S sent notices to California health plans rescinding or reducing previously announced price hikes on at least 10 drugs.